The current state of brachytherapy nomograms for patients with clinically localized prostate cancer.

Abstract:

:For men diagnosed with clinically localized prostate cancer, definitive therapy with radical prostatectomy, external beam radiation therapy, or brachytherapy offers a high chance of cure. Currently, there are insufficient data to recommend 1 treatment approach over another, leaving physicians and patients to decide based on their own biases and preferences. Prediction tools, such as nomograms and probability tables, have been created as decision aids to facilitate patient counseling and decision making. Nomograms in particular can assess the therapeutic efficacy of a given therapy by providing individualized estimates of the risk of failure after treatment. The authors performed a comprehensive literature review to identify nomograms assessing the efficacy of brachytherapy in patients with clinically localized prostate cancer, and found a paucity of such models. Analysis of currently available brachytherapy nomograms reveals suboptimal predictive power compared with models based on other treatment modalities. The purpose of this review is to spur development of new and more accurate prediction tools for predicting outcomes after brachytherapy, offering physicians and patients the opportunity to equally assess the efficacy of all available treatment modalities for clinically localized prostate cancer. Cancer 2009;115(13 suppl):3121-7. (c) 2009 American Cancer Society.

journal_name

Cancer

journal_title

Cancer

authors

Nguyen CT,Zelefsky MJ,Kattan MW

doi

10.1002/cncr.24344

subject

Has Abstract

pub_date

2009-07-01 00:00:00

pages

3121-7

issue

13 Suppl

eissn

0008-543X

issn

1097-0142

journal_volume

115

pub_type

杂志文章,评审

相关文献

CANCER文献大全
  • Phase I-II trial of percutaneous intra-arterial cis-diamminedichloro platinum (II) for regionally confined malignancy.

    abstract::Forty-nine patients with regionally confined recurrent malignancy were treated with intra-arterial cis-diamminedichloro platinum II in a Phase I-II trial. A safe starting dose of 120 mg/m2 was established. An overall response rate of 45% was noted with significant responses observed among patients with melanoma, sarco...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19800315)45:6<1278::aid-cncr2820

    authors: Calvo DB 3rd,Patt YZ,Wallace S,Chuang VP,Benjamin RS,Pritchard JD,Hersh EM,Bodey GP Sr,Mavligit GM

    更新日期:1980-03-15 00:00:00

  • Experimental studies on the radiation-modifying effect of cis-diamminedichloroplatinum II (DDP) in human bladder transitional cell carcinomas grown in nude mice.

    abstract::The effect of cis-diamminedichloroplatinum II (DDP) and ionizing radiation on human bladder transitional cell carcinoma (TCC) was evaluated in nude mouse-grown human tumors following administration of single-agent and combination treatment. Combination of DDP and radiation resulted in accelerated tumor regression and ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19830801)52:3<452::aid-cncr28205

    authors: Kyriazis AP,Yagoda A,Kereiakes JG,Kyriazis AA,Whitmore WF Jr

    更新日期:1983-08-01 00:00:00

  • Pregnancy outcome in cancer patients. Experience in a large cooperative group.

    abstract::To evaluate the potential teratogenicity and mutagenicity of modern cancer treatment, the authors enumerated from a cooperative clinical trial group 133 pregnancies in 66 women with malignant neoplasms (53% with Hodgkin's disease, 26% with other lymphomas and leukemia, and 21% with solid tumors). The gestations were d...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19870901)60:5<1143::aid-cncr2820

    authors: Mulvihill JJ,McKeen EA,Rosner F,Zarrabi MH

    更新日期:1987-09-01 00:00:00

  • Oxaliplatin and capecitabine in the treatment of patients with recurrent or refractory carcinoma of unknown primary site: a phase 2 trial of the Sarah Cannon Oncology Research Consortium.

    abstract:BACKGROUND:Despite the widespread use of oxaliplatin-based regimens for colorectal and other gastrointestinal cancers, there is surprisingly little information regarding their empiric use for the treatment of carcinoma of unknown primary site (CUP). In the current study, the combination of oxaliplatin and capecitabine ...

    journal_title:Cancer

    pub_type: 杂志文章,多中心研究

    doi:10.1002/cncr.25029

    authors: Hainsworth JD,Spigel DR,Burris HA 3rd,Shipley D,Farley C,Macias-Perez IM,Barton J,Greco FA

    更新日期:2010-05-15 00:00:00

  • Establishment of three bleomycin-resistant human carcinoma cell lines and their cross-resistance to other antitumor agents.

    abstract::Three bleomycin-resistant (BLMr) human carcinoma cell lines (HeLa-BLMr, KB-BLMr, and Hepd-uvBLMr) were established in culture by progressively increasing the concentration of bleomycin (BLM). HeLa-BLMr and KB-BLMr were obtained after 5 and 2 months of incubation with BLM, whereas the establishment of Hepd-uvBLMr requi...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19880415)61:8<1501::aid-cncr2820

    authors: Urade M,Sugi M,Miyazaki T

    更新日期:1988-04-15 00:00:00

  • Observations on growth rate of breast carcinomas and its possible implications for lead time.

    abstract::Doubling times were estimated for 15 breast carcinomas in 13 patients, and were found to be between 42 and 397 days with the average at 211 days. The mean lead time at mean growth rate from the average size of 44 preclinical to the average size of 118 clinical tumors was estimated to be 3 years. This period may be con...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197710)40:4<1722::aid-cncr282040

    authors: Lundgren B

    更新日期:1977-10-01 00:00:00

  • Transient neurologic disturbances induced by high-dose methotrexate treatment.

    abstract::Temporary neurologic abnormalities were detected in 9 of 60 patients undergoing treatment with high-dose methotrexate and citrovorum factor rescue (MTX-CF) for osteosarcoma. The incidence of abnormalities and abnormalities themselves were more severe than previously reported. This was attributed to an increased dose a...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19850915)56:6<1356::aid-cncr2820

    authors: Jaffe N,Takaue Y,Anzai T,Robertson R

    更新日期:1985-09-15 00:00:00

  • Oral bisphosphonates: A review of clinical use in patients with bone metastases.

    abstract:BACKGROUND:This study was conducted to review the efficacy and safety of oral bisphosphonates for the treatment of bone metastases in cancer patients. METHODS:Available published clinical studies of oral bisphosphonates in bone metastases from 1980 to the present were identified through a MEDLINE search and from liter...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Major PP,Lipton A,Berenson J,Hortobagyi G

    更新日期:2000-01-01 00:00:00

  • Focal heating of V-2 tumors with a hybrid radiofrequency applicator.

    abstract::A hybrid radiofrequency heating system previously reported to produce highly focused heating patterns at less than or equal to 10 cm depth in phantom models was utilized to selectively heat hypervascular, heat resistant rabbit V-2 tumors implanted in the left hindlimb. Spheroidal heating patterns 3 to 4 cm in diameter...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19850315)55:6<1172::aid-cncr2820

    authors: Boddie AW Jr,Merritt DR,Yamanashi W,Frazer JW,McBride CM,Martin RG

    更新日期:1985-03-15 00:00:00

  • The DNA content of human plasma cells.

    abstract::The DNA content of human plasma cells from myeloma patients relative to that of leukocytes was determined by flow and microscopic cytofluorometry after propidium iodide and fluorescent Feulgen staining, respectively. Mononucleated myeloma plasma cells from all of the 17 patients studied contained more DNA (17 to 58%) ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19810515)47:10<2433::aid-cncr282

    authors: Brox L,Mowles D,Pollock B,Belch A

    更新日期:1981-05-15 00:00:00

  • Angiogenesis in adenocarcinoma of the uterine cervix.

    abstract:BACKGROUND:Angiogenesis is essential for tumor growth, progression, and metastases. Microvessel density (MVD), a measure of tumor angiogenesis, has been found to have prognostic significance in many tumor types for predicting metastasis and survival. METHODS:Between 1979-1989, 56 cases of FIGO Clinical Stage I and II ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/(sici)1097-0142(19981001)83:7<1384::aid-cn

    authors: Kaku T,Hirakawa T,Kamura T,Amada S,Kinukawa N,Kobayashi H,Sakai K,Ariyoshi K,Sonoda K,Nakano H

    更新日期:1998-10-01 00:00:00

  • Myoepithelial cell-rich neoplasms: cytologic features of benign and malignant lesions.

    abstract:BACKGROUND:Lesions that contain abundant myoepithelial cells may present as a diagnostic challenge in fine-needle aspiration (FNA) specimens. Potential diagnostic problems may arise due to morphologic heterogeneity of myoepithelial cell-rich lesions and difficulty in predicting malignancy in FNA specimens. An accurate ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.20642

    authors: Darvishian F,Lin O

    更新日期:2004-12-25 00:00:00

  • Phase I and pharmacokinetic study of a stable, polyethylene-glycolated liposomal doxorubicin in patients with solid tumors: the relation between pharmacokinetic property and toxicity.

    abstract:BACKGROUND:Compared with free drug, sterically stabilized liposomal drug has prolonged circulation time and, thereby, higher tumor selectivity and antitumor activity. The stability in plasma is an important consideration in the formulation of clinically useful liposomal drug. A Phase I study of a stable liposomal doxor...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:

    authors: Hong RL,Tseng YL

    更新日期:2001-05-01 00:00:00

  • The natural history of neoplastic development: the relation of experimental models to human cancer.

    abstract::The natural history of the development of neoplasia in experimental systems may be separated into at least three different stages, those of initiation, promotion and progression. Evidence for such distinct stages has been demonstrated in at least half a dozen different experimental systems. The stage of promotion is t...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19820315)49:6<1206::aid-cncr2820

    authors: Pitot HC

    更新日期:1982-03-15 00:00:00

  • Parametrial implant in Stage III B cancer of the cervix. III. A five-year study.

    abstract::Since 1975, the Department of Radiation Therapy, University of Maryland Hospital initiated a policy of supplementing the dose to the affected parametrium by using radium needles implants in conjunction with a protruding tandem preferably, or Manchester ovoid in the case of absence of the lower segment of the uterus. T...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19830815)52:4<748::aid-cncr28205

    authors: Prempree T

    更新日期:1983-08-15 00:00:00

  • Prognostic value of DNA ploidy and c-erbB-2 oncoprotein overexpression in adenocarcinoma of Barrett's esophagus.

    abstract:BACKGROUND:During the last two decades, a rising incidence of adenocarcinoma of the esophagus has been observed in the Western world. The prognostic relevance of tumor-biological factors, such as DNA ploidy or c-erbB-2 overexpression, for overall survival following complete resection is still unknown. METHODS:In a ret...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19940401)73:7<1785::aid-cncr2820

    authors: Nakamura T,Nekarda H,Hoelscher AH,Bollschweiler E,Harbeck N,Becker K,Siewert JR,Harbec N corrected to Harbeck N

    更新日期:1994-04-01 00:00:00

  • Dose intensity analysis of high-dose carboplatin in refractory ovarian carcinoma relative to age.

    abstract:BACKGROUND:Cisplatin and carboplatin are essential to management of advanced-stage epithelial ovarian carcinoma. No published data exist regarding carboplatin dose intensity importance in ovarian cancer, nor are there data for the effect of age on the ability to deliver dose-intensive carboplatin. METHODS:Retrospectiv...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:10.1002/cncr.2820710225

    authors: Cornelison TL,Reed E

    更新日期:1993-01-15 00:00:00

  • Double alkylating agent therapy with ifosfamide and cyclophosphamide for advanced non-small cell lung cancer. From the Manchester Lung Tumour Group.

    abstract::Forty-five patients with advanced non-small cell lung cancer (NSCLC), with progressive inoperable tumors were treated. Twenty-three patients were of "limited" stage. Six patients had received previous thoracic radiotherapy. Patients with central nervous system (CNS) metastases, Karnofsky scores of less than 30 or more...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19880101)61:1<14::aid-cncr282061

    authors: Thatcher N,Smith DB,Lind MJ,Anderson H,Barclay J,Chopra MP,Fitzgerald MD

    更新日期:1988-01-01 00:00:00

  • Treatment of acute leukemia in adults.

    abstract::Improvement in the management of acute leukemia in adults has not progressed nearly so rapidly as has the treatment of childhood leukemia. One important difference is that most adults have myeloblastic or related forms of the disease (AML), whereas the majority of children have lymphoblastic leukemia (ALL). However, e...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197508)36:2+<775::aid-cncr282036

    authors: Clarkson BD,Dowling MD,Gee TS,Cunningham IB,Burchenal JH

    更新日期:1975-08-01 00:00:00

  • Response to 5-azacytidine in patients with refractory acute nonlymphocytic leukemia and association with chromosome findings.

    abstract::Fifteen patients with acute nonlymphocytic leukemia (ANLL) who either had a relapse after a previous complete remission (nine patients) or progressive disease after initial induction attempts with combination chemotherapy (six patients) were treated with 5-azacytidine. Five patients (33%) achieved a complete remission...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19820601)49:11<2222::aid-cncr282

    authors: Larson RA,Sweet DL,Golomb HM,Testa JR,Rowley JD

    更新日期:1982-06-01 00:00:00

  • Patterns of recurrence following curative resection alone for adenocarcinoma of the rectum and sigmoid colon.

    abstract::Two-hundred-four patients with previously untreated adenocarcinoma of rectum, rectosigmoid, and sigmoid colon were retrospectively evaluated to determine patterns of recurrence following curative resection. Seventy-eight (38%) subsequently developed recurrent disease. Of these, 40% (31/78) presented with local recurre...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19810915)48:6<1492::aid-cncr2820

    authors: Rao AR,Kagan AR,Chan PM,Gilbert HA,Nussbaum H,Hintz BL

    更新日期:1981-09-15 00:00:00

  • Cancer prevention and detection. An overview of variables influencing adoption and practice.

    abstract::This paper presents an overview of factors, attitudes, and beliefs that may influence the adoption of cancer prevention and detection strategies by health-care providers and the public. Health-care practitioners require education about prevention and detection approaches to health care and the social variations in the...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/1097-0142(19880601)61:11+<2391::aid-cncr28

    authors: Fink DJ,Sheehan HE

    更新日期:1988-06-01 00:00:00

  • Systemic aspergillosis as cause of myocardial infarction.

    abstract::Systemic aspergillosis is encountered with increasing prevalence in immunocompromised patients undergoing chemotherapy. The current communication describes the clinical and postmortem findings in three leukemic patients who developed myocardial infarction secondary to Aspergillus embolization of the coronary arteries....

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19861101)58:9<2146::aid-cncr2820

    authors: Andersson BS,Luna MA,McCredie KB

    更新日期:1986-11-01 00:00:00

  • The future of cancer screening after COVID-19 may be at home.

    abstract:LAY SUMMARY:During the coronavirus disease 2019 (COVID-19) pandemic, cancer screening decreased precipitously; home screening for colorectal cancer diminished less than that for colonoscopy and breast and cervical cancer screening. The authors have highlighted approaches for home cancer screening in addition to telemed...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.33274

    authors: Gorin SNS,Jimbo M,Heizelman R,Harmes KM,Harper DM

    更新日期:2021-02-15 00:00:00

  • Imaging for improved prediction of myelotoxicity after radioimmunotherapy.

    abstract:BACKGROUND:The severity of myelotoxicity after radioimmunotherapy has been predicted from body and blood radiation doses to marrow. However, marrow radiation can be increased substantially if the marrow or skeleton contains the malignancy targeted by the radiolabeled monoclonal antibodies. A study of 29 patients treate...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/(sici)1097-0142(19971215)80:12+<2558::aid-

    authors: DeNardo DA,DeNardo GL,O'Donnell RT,Lim SM,Shen S,Yuan A,DeNardo SJ

    更新日期:1997-12-15 00:00:00

  • Antifungal treatment by amphotericin B and 5-fluorocytosine delays the recovery of normal hematopoietic cells after intensive cytostatic therapy for acute myeloid leukemia.

    abstract::Systemic fungal infections are recognized at increasing frequency during the course of intensive therapy for acute leukemias and require parenteral antifungal treatment mostly by amphotericin B (ampho B) alone or in combination with 5-Fluorocytosine (5-FC). Because of the potential myelosuppressive side effects of 5-F...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:10.1002/1097-0142(19910701)68:1<9::aid-cncr2820680

    authors: Hiddemann W,Essink ME,Fegeler W,Zühlsdorf M,Sauerland C,Büchner T

    更新日期:1991-07-01 00:00:00

  • Comparative evaluation of combined radiation-chlorambucil treatment of ovarian carcinomatosis.

    abstract::In a study conducted by the Eastern Cooperative Oncology Group, 51 evaluable women with advanced ovarian carcinoma were randomized to either abdominal radiation therapy alone, chlorambucil alone, or to a combination of radiation therapy and chlorambucil by members of the Eastern Cooperative Oncology Group. Provision w...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1002/1097-0142(197511)36:5<1625::aid-cncr282036

    authors: Miller SP,Brenner S,Horton J,Stolbach L,Shnider BI,Pocock S

    更新日期:1975-11-01 00:00:00

  • Biliary reflux as a causal factor in hypopharyngeal carcinoma: New clinical evidence and implications.

    abstract:BACKGROUND:Recent preclinical explorations strongly support the tumorigenic potential of bile on laryngopharyngeal mucosa. Herein, the authors describe, in bile-related human hypopharyngeal squamous cell carcinoma (HSCC), NF-κB-related messenger RNA (mRNA) and microRNA (miRNA) oncogenic phenotypes similar to those prev...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.32369

    authors: Sasaki CT,Doukas SG,Costa J,Vageli DP

    更新日期:2019-10-15 00:00:00

  • Clinicopathologic features associated with efficacy and long-term survival in metastatic melanoma patients treated with BRAF or combined BRAF and MEK inhibitors.

    abstract:BACKGROUND:The degree of response and the duration of survival of patients treated with mitogen-activated protein kinase (MAPK) inhibitors are highly variable. Whether baseline clinicopathologic factors can predict the clinical course with treatment is largely unknown. METHODS:For 142 consecutive immunotherapy- and MA...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.29586

    authors: Menzies AM,Wilmott JS,Drummond M,Lo S,Lyle M,Chan MM,Thompson JF,Guminski A,Carlino MS,Scolyer RA,Kefford RF,Long GV

    更新日期:2015-11-01 00:00:00

  • Review of four cases of childhood hepatic angiosarcoma--elevated environmental arsenic exposure in one case.

    abstract::Four cases of childhood hepatic angiosarcoma (HAS), representing the malignant form of infantile hemangioendothelioma, are described. The morphologic appearance of childhood HAS differs from the adult form in the following features: the associated presence of benign infantile hemangioendothelioma; the presence of dyso...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19810115)47:2<382::aid-cncr28204

    authors: Falk H,Herbert JT,Edmonds L,Heath CW Jr,Thomas LB,Popper H

    更新日期:1981-01-15 00:00:00